# Interleukin-2 in Treating Patients With Mycosis Fungoides

> **NCT00002687** · PHASE1 · COMPLETED · sponsor: **University of Washington** · enrollment: 30 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** aldesleukin

## Key facts

- **NCT ID:** NCT00002687
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-02
- **Primary completion:** 2003-07
- **Final completion:** 2003-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2012-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002687, "Interleukin-2 in Treating Patients With Mycosis Fungoides". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00002687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*